[ad_1]
Metropolis Healthcare clarified on the stock exchanges that its promoters have no intention to exit the business after rumours were rife that the Shah family is looking to sell its controlling stake to a strategic investor.
The national diagnostic chain said that it is continuously exploring various strategic options and investment opportunities. Thus, it keeps receiving inbound interest from financial institutions and companies for a potential minority stake purchase in Metropolis Healthcare.
“The company, its promoters and management team are committed to operating Metropolis Healthcare Ltd with the highest standards of medical science, stakeholder trust and customer engagement,” the company said.
A couple of media reports have suggested that the company’s promoters have initiated a formal process to sell their stake and have roped in investment banking firm Barclays to handle the process.
“The company, its promoters and management team are committed to operating Metropolis Healthcare Limited with the highest standards of medical science, stakeholder trust and customer engagement. Promoters have no intention to exit the business and are in fact focused on strengthening the Metropolis Brand,” the company clarified on the BSE.
“Any step taken by the Promoters and Management Team will be in the view of long-term growth prospects of the company and in the best interest of all stakeholders,” it added.
Metropolis has a presence across 20 states in the country. Its shares tumbled 1.35 per cent in morning trade on Tuesday.
Dear Reader,
Business Standard has always strived hard to provide up-to-date information and commentary on developments that are of interest to you and have wider political and economic implications for the country and the world. Your encouragement and constant feedback on how to improve our offering have only made our resolve and commitment to these ideals stronger. Even during these difficult times arising out of Covid-19, we continue to remain committed to keeping you informed and updated with credible news, authoritative views and incisive commentary on topical issues of relevance.
We, however, have a request.
As we battle the economic impact of the pandemic, we need your support even more, so that we can continue to offer you more quality content. Our subscription model has seen an encouraging response from many of you, who have subscribed to our online content. More subscription to our online content can only help us achieve the goals of offering you even better and more relevant content. We believe in free, fair and credible journalism. Your support through more subscriptions can help us practise the journalism to which we are committed.
Support quality journalism and subscribe to Business Standard.
Digital Editor
[ad_2]
Source link
